This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Merck Sharp + Dohme B.v., Other. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 55 
1 out of 834,570 Years Active: 2012-2014
Title: Ashvinkumar Dhirubhai Mistry: Innovator in Pharmaceutical Chemistry
Introduction
Ashvinkumar Dhirubhai Mistry is a notable inventor based in Newhouse, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Mistry's work focuses on developing new therapeutic compounds.
Latest Patents
Mistry's latest patents include the invention of tricyclic heterocyclic derivatives. This invention relates to a tricyclic heterocyclic derivative according to a specific formula, which can be used in pharmaceutical compositions for treating serotonin-mediated disorders, such as obesity. Another significant patent involves (pyrrolidin-2-yl)phenyl derivatives, which are designed for the treatment of pain, including neuropathic and inflammatory pain. These compounds also have potential applications in various pharmaceutical formulations.
Career Highlights
Throughout his career, Mistry has worked with prominent companies, including Merck Sharp & Dohme B.V. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health issues.
Collaborations
Mistry has collaborated with notable professionals in his field, including Keneth Davies and Takao Kiyoi. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Ashvinkumar Dhirubhai Mistry is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patents reflect a commitment to improving therapeutic options for various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile